Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
19
2022
A Third Surge in Innovation and Patents on Hydrogen Fuel Cell Vehicles Foley & Lardner LLP
Jul
18
2022
Target Argues Consumer Deception is Implausible for Bright Red, Zero-Calorie, Water Enhancer Keller and Heckman LLP
Jul
18
2022
EC Requests Scientific Opinion on Titanium Dioxide in Cosmetic Products Bergeson & Campbell, P.C.
Jul
18
2022
Camp Lejeune Water Contamination Lawsuits Buckfire Law
Jul
18
2022
Kardashian’s ‘SKKN by Kim’ Brand Facing Legal Uncertainty Proskauer Rose LLP
Jul
18
2022
The Waiting Is the Hardest Part: Alabama Medical Cannabis Commission Announces Updated Timetable for Licenses Bradley Arant Boult Cummings LLP
Jul
18
2022
Commission Approves State Aid For IPCEI In Hydrogen K&L Gates
Jul
16
2022
FDA Greenlights Pharmacists to Prescribe COVID-19 Drug Paxlovid Epstein Becker & Green, P.C.
Jul
15
2022
Austrian Academy of Sciences Publishes NanoTrust Dossier on Advanced Materials Bergeson & Campbell, P.C.
Jul
15
2022
In Mexico, a Reform Project Is Being Discussed That Contains Restrictive Measures for the Advertising and Marketing of Products Containing Tobacco OLIVARES
Jul
15
2022
New FDA Draft Guidance Aiming to Prevent Drug Shortages Will Affect Pharmaceutical Manufacturers K&L Gates
Jul
15
2022
Gerber Argues FDA Preemption in Baby Food Lawsuit Keller and Heckman LLP
Jul
15
2022
EPA Issues a Proposed Consent Decree Regarding Petition Concerning Treated Seeds and Treated Article Exemption Bergeson & Campbell, P.C.
Jul
14
2022
Finding a Bank and Insurance Company for a Cannabis Business Bradley Arant Boult Cummings LLP
Jul
14
2022
Federal Court Rules That FDA Was Arbitrary and Capricious in Deeming Premium Cigars Subject to the Tobacco Control Act Keller and Heckman LLP
Jul
14
2022
Sustainability Outlook European Union - June 2022 Squire Patton Boggs (US) LLP
Jul
14
2022
FDA Approves Six Accreditation Bodies Under LAAF Keller and Heckman LLP
Jul
14
2022
USDA Announces NIFA Bioproduct Pilot Program Bergeson & Campbell, P.C.
Jul
13
2022
Mexico Issues New NOM for Good Manufacturing Practices (GMP) Regarding Cosmetic Products. OLIVARES
Jul
13
2022
Superfund Tax on Chemicals: What You Need to Know to Comply Bergeson & Campbell, P.C.
Jul
13
2022
FTC’s PBM Study Signals Broader Federal Scrutiny of the Prescription Drug Sector Epstein Becker & Green, P.C.
Jul
13
2022
The FTC's "New" Tool: Greater Enforcement of the Robinson-Patman Act K&L Gates
Jul
13
2022
Presentations Available from 4th Joint Symposium on Nanotechnology Bergeson & Campbell, P.C.
Jul
13
2022
FDA Warns 4 Companies for Selling Tainted Honey-Based Products Keller and Heckman LLP
Jul
13
2022
Infant Formula Shortage Update Proskauer Rose LLP
Jul
12
2022
China on the Move: Proposed Pharmaceutical Regulations Would Comprehensively Reform Regulatory Landscape Greenberg Traurig, LLP
Jul
12
2022
FDA’s Review of Pulse Oximeter Performance Continues a Trend in Addressing Biases in Digital Health Technologies Mintz
Jul
12
2022
FDA to Develop Framework for Continued Expanded Access to Infant Formula Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins